ARTACENT FLEX Trademark

Trademark Overview


On Thursday, November 5, 2015, a trademark application was filed for ARTACENT FLEX with the United States Patent and Trademark Office. The USPTO has given the ARTACENT FLEX trademark a serial number of 86810254. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, April 3, 2023. This trademark is owned by Harbinger Medical Group, LLC. The ARTACENT FLEX trademark is filed in the Pharmaceutical Products category with the following description:

human allograft tissue; biological tissue grafts; biological amniotic tissue intended for subsequent implantation
artacent flex

General Information


Serial Number86810254
Word MarkARTACENT FLEX
Filing DateThursday, November 5, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, April 3, 2023
Registration Number5088165
Registration DateTuesday, November 22, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2016

Trademark Statements


Goods and Serviceshuman allograft tissue; biological tissue grafts; biological amniotic tissue intended for subsequent implantation
NOT AVAILABLE"FLEX"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 10, 2015
Primary Code005
First Use Anywhere DateThursday, August 11, 2016
First Use In Commerce DateThursday, August 11, 2016

Trademark Owner History


Party NameTIDES MEDICAL, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressLAFAYETTE, LA 70508

Party NameHarbinger Medical Group, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLafayette, LA 70508

Party NameHarbinger Medical Group, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLafayette, LA 70508

Party NameHarbinger Medical Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLafayette, LA 70508

Trademark Events


Event DateEvent Description
Monday, November 9, 2015NEW APPLICATION ENTERED
Monday, February 29, 2016ASSIGNED TO EXAMINER
Monday, March 21, 2016ASSIGNED TO LIE
Tuesday, November 10, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 4, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, March 4, 2016EXAMINERS AMENDMENT E-MAILED
Friday, March 4, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 4, 2016EXAMINER'S AMENDMENT ENTERED
Friday, March 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 14, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 22, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2016PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 21, 2016TEAS STATEMENT OF USE RECEIVED
Wednesday, September 21, 2016USE AMENDMENT FILED
Tuesday, October 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 12, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, April 3, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, October 15, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 22, 2016REGISTERED-PRINCIPAL REGISTER
Monday, November 22, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 20, 2022TEAS SECTION 8 & 15 RECEIVED
Friday, March 31, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 28, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, April 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED